Main Street Financial Solutions’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.18M Buy
12,932
+4,238
+49% +$688K 0.16% 127
2025
Q3
$1.26M Sell
8,694
-205
-2% -$28K 0.08% 214
2025
Q2
$1.13M Sell
8,899
-274
-3% -$33.6K 0.08% 208
2025
Q1
$1.17M Buy
9,173
+1,131
+14% +$153K 0.1% 174
2024
Q4
$1.06M Sell
8,042
-110
-1% -$15.5K 0.1% 156
2024
Q3
$1.19M Buy
8,152
+150
+2% +$21.7K 0.11% 170
2024
Q2
$1.1M Buy
8,002
+82
+1% +$10.9K 0.1% 187
2024
Q1
$1.09M Buy
7,920
+19
+0.2% +$2.6K 0.12% 166
2023
Q4
$1.07M Sell
7,901
-47
-0.6% -$5.73K 0.14% 142
2023
Q3
$972K Buy
7,948
+65
+0.8% +$8.27K 0.14% 145
2023
Q2
$1M Sell
7,883
-144
-2% -$18.7K 0.13% 151
2023
Q1
$1.04M Sell
8,027
-295
-4% -$38.6K 0.15% 146
2022
Q4
$1.09M Sell
8,322
-492
-6% -$63.6K 0.17% 125
2022
Q3
$1.03M Sell
8,814
-61
-0.7% -$7.58K 0.17% 127
2022
Q2
$1.04M Buy
8,875
+116
+1% +$13.8K 0.13% 142
2022
Q1
$1.14M Buy
8,759
+97
+1% +$12.6K 0.17% 129
2021
Q4
$1.32M Sell
8,662
-421
-5% -$65.2K 0.19% 121
2021
Q3
$1.47M Buy
9,083
+514
+6% +$86.5K 0.23% 104
2021
Q2
$1.4M Buy
8,569
+566
+7% +$87.2K 0.23% 106
2021
Q1
$1.21M Buy
8,003
+788
+11% +$125K 0.21% 111
2020
Q4
$1.09M Buy
+7,215
New +$1.03M 0.22% 107

Other funds holding IBB

Main Street Financial Solutions's IBB Position: Q4 2025 in Review

Main Street Financial Solutions increased its iShares Biotechnology ETF (IBB) stake by 49% in Q4 2025, buying an estimated $688K and bringing the position to 12,932 shares worth $2.18M. The position accounts for 0.16% of the portfolio, ranked #127.

Main Street Financial Solutions first reported a position in IBB in Q4 2020 and has held it in 21 quarters since. 955 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Main Street Financial Solutions held 12,932 shares of iShares Biotechnology ETF worth $2.18M as of Q4 2025.
  • Main Street Financial Solutions bought 4,238 iShares Biotechnology ETF shares in Q4 2025, an estimated $688K.
  • iShares Biotechnology ETF made up 0.16% of Main Street Financial Solutions's portfolio in Q4 2025, its #127 holding.
  • Main Street Financial Solutions first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 21 quarters since.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Main Street Financial Solutions's 13F filing for Q4 2025, filed 17 Feb 2026.